Recognizing the importance of acute and chronic renal failures (acute kidney injury and end-stage renal disease) and their morbidity, mortality if left untreated, among children, young mothers and adults.
Recognizing the lack of diagnostic and treatment of acute and chronic renal failures (acute kidney injury and end-stage renal disease) in low and middle-income countries, given that 80% of patients receiving renal replacement therapy reside in Europe, North America, or Japan (representing 12% of the world population)
Recognizing the following as the main reasons for this state of affairs:
-
Limited capacity to provide dialysis treatment, which is mostly dedicated to the wealthiest patients and for acute kidney injury patients. There are only a few dozens of hemodialysis generators per low-income country and affordable sterile peritoneal dialysis solutions are largely unavaible.
-
The high cost of dialysis as dialysis is either an expensive equipment-driven treatment (hemodialysis) or dependent on large amounts of sterile dialysis solutions (peritoneal dialysis). Besides, both equipment and solutions are manufactured by large corporations that only target the most developed countries with sophisticated, hence costly products.
-
High technical complexity of dialysis treatment (sophisticated dialysis machines, need of large amount of ultra-pure water and stable energy supply, need of drug treatment in complement to dialysis sessions (erythropoiesis stimulating agents, nutrition supplement, anticoagulant, etc.)
-
Lack of expertise among the health workers (low number of graduated nephrologists, of trained nurses…)
-
Necessity to closely monitor patients and do blood analysis on a regular basis.
-
Risks of severe infection for dialysis patients.
-
Treatment facilities available only in major cities, when available at all, requiring patients to travel long distances to seek care.
-
Absence of kidney disease register, epidemiologic data, medical guidelines, etc.
